Investing.com - Financial Markets Worldwide

Choong Ang Vaccine Laboratory (072020)

KOSDAQ
Currency in KRW
9,920
+40(+0.40%)
Closed·

072020 Financial Summary

Key Ratios

P/E Ratio26.58
Price/Book1
Debt / Equity11.6%
Return on Equity3.83%
Dividend Yield1.71%
EBITDA10.34B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2006
31/12
2007
31/12
2008
31/12
2009
31/12
2010
31/12
2011
31/12
2012
31/12
2020
31/12
2021
31/12
2022
31/12
Income Statement
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa15,589.2919,263.3436,317.5340,913.939,299.16
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa8,061.5111,204.3716,784.3318,439.118,645.3
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa2,821.764,422.144,030.954,541.344,282.86
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa2,367.514,371.773,163.797,601.864,044.46
Balance Sheet
Total Assets
aa.aaaa.aaaa.aaaa.aaaa.aa42,408.0550,817.28104,979.27112,952.18114,858.58
Total Current Liabilities
aa.aaaa.aaaa.aaaa.aaaa.aa1,930.374,805.4512,453.5314,361.1713,312.94
Total Equity
aa.aaaa.aaaa.aaaa.aaaa.aa40,082.9544,120.8687,549.8892,976.0295,304.45
Cash Flow
Levered Free Cash Flow
aa.aaaa.aaaa.aaaa.aaaa.aa--4,598.97--4,504.3-2,886.7
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa4,936.315,159.338,315.711,525.477,085.71
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-4,457.49-7,837.47-13,147.84-11,999.91-9,181.19
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-187.323,0323,928.88-876.9-1,600.32
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa294.76299.09-1,116.38-944.28-3,488.86
* In Millions of KRW (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 375.11%
Dividend Yield
1.71%
Industry Median 0.93%
Annualised payout
170.00
Paid annually
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
Nov 14, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
a
a
Unlock
Last 90 days

FAQ

What was Choong Ang Vaccine Laboratory's net income for the latest quarter?

Choong Ang Vaccine Laboratory's net income for the latest quarter was 1,853.38.

How did Choong Ang Vaccine Laboratory's performance compare year-over-year in the latest quarter?

The company's revenue moved from 9,054.88 in the previous quarter to 10,230.24 in the latest quarter, and net income moved from -1,687.22 to 1,853.38 compared to the previous quarter.

What is Choong Ang Vaccine Laboratory's net profit margin on a TTM basis?

Choong Ang Vaccine Laboratory's trailing twelve months (TTM) net profit margin is 10.29%.

How does Choong Ang Vaccine Laboratory's debt to equity ratio compare to industry standards?

Choong Ang Vaccine Laboratory's total debt-to-equity ratio is 11.60%.

What is Choong Ang Vaccine Laboratory's return on investment on a TTM basis?

Choong Ang Vaccine Laboratory's trailing twelve months (TTM) return on investment (ROI) is 3.83%.

Did Choong Ang Vaccine Laboratory gain or lose cash last quarter?

In the latest quarter, Choong Ang Vaccine Laboratory's net change in cash was 5,151.39 million.

What were Choong Ang Vaccine Laboratory's total assets and liabilities in the latest quarter?

As of the latest quarter, Choong Ang Vaccine Laboratory reported total assets of 114,699.16 million and total liabilities of 13,407.29 million.

How has Choong Ang Vaccine Laboratory's total revenue grown this year?

Choong Ang Vaccine Laboratory's total revenue was 9,054.88 in the previous quarter and 10,230.24 in the latest quarter.

What was Choong Ang Vaccine Laboratory's revenue per share for the latest quarter?

Choong Ang Vaccine Laboratory's revenue per share for the latest quarter was 14,346.77.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.